Shopping Cart
- Remove All
- Your shopping cart is currently empty
SR1664 is a potent and selective PPARγ inhibitor with potential antidiabetic activity. SR1664 binds to PPARγ and potently inhibits Cdk5-mediated PPARγ phosphorylation (IC50 = 80 nM; Ki = 28.67 nM) without exhibiting PPARγ agonist activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 45 € | In Stock | |
2 mg | 64 € | In Stock | |
5 mg | 107 € | In Stock | |
10 mg | 139 € | In Stock | |
25 mg | 305 € | In Stock | |
50 mg | 543 € | In Stock | |
100 mg | 780 € | In Stock | |
500 mg | 1.605 € | In Stock | |
1 mL x 10 mM (in DMSO) | 118 € | In Stock |
Description | SR1664 is a potent and selective PPARγ inhibitor with potential antidiabetic activity. SR1664 binds to PPARγ and potently inhibits Cdk5-mediated PPARγ phosphorylation (IC50 = 80 nM; Ki = 28.67 nM) without exhibiting PPARγ agonist activity. |
Targets&IC50 | PPARγ:28.67 nM(Ki), PPARγ:80 nM |
In vitro | Mutagenesis of F282 to alanine (F282A) altered the pharmacology of SR1664 on PPARγ activity, acting as an agonist of the mutant receptor in a transcriptional activity assay, and differentially displacing nuclear receptor co-repressor 1. Together these results suggest that SR1664 actively antagonizes PPARγ through a stereo-specific AF2-mediated, F282-dependent clash, and that stereospecificity confers antagonism within the biaryl indole scaffold[1]. |
Alias | SR 1664 |
Molecular Weight | 547.6 |
Formula | C33H29N3O5 |
Cas No. | 1338259-05-4 |
Smiles | C[C@H](NC(=O)c1ccc2n(Cc3ccc(cc3)-c3ccccc3C(O)=O)c(C)c(C)c2c1)c1ccc(cc1)[N+]([O-])=O |
Relative Density. | 1.27 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/ml (109.57 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.